Ginkgo bioworks announces participation in cowen's 43rd annual health care conference

Boston , march 2, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, announced today that co-founder and ceo jason kelly is scheduled to participate in cowen's 43rd annual health care conference, including: fireside chat on monday, march 6, 2023, at 9:10 a.m. et synbio & ai driven drug discovery panel on monday, march 6, 2023, at 4:40 p.m.
DNA Ratings Summary
DNA Quant Ranking